Join USP for an intensive workshop exploring the critical role of pharmacopeial standards in ensuring biologics quality. This hands-on session will focus on practical applications of USP monoclonal antibody (mAb) standards and best practices for biologics development.
Program Highlights:
- USP Biologics Solutions Overview
- Practical Applications of USP mAb Standards
- Interactive Q&A with USP Experts
- USP Efforts to Develop Quality Standards for Cell and Gene Therapy Products (Singapore and live-virtual session)
Key Topics:
- Validation of In-House Methods and Materials
- Bridging Drift or Differences from Batch to Batch
- For Innovators; When there is No Reference Product
- Cross-Platform mAb Degradation Testing
- Challenges in CAR T Manufacturing (Singapore and live-virtual session)
- Step-wise Utilization of USP AAV Solutions (Singapore and live-virtual session)
Benefits of Attending:
- Learn practical applications of pharmacopeial standards
- Discover tools to accelerate biologics R&D
- Engage directly with USP experts
- Network with industry peers
Workshop Schedule: Contact USP_APAC@usp.org for inquiries
South Korea
- February 18, 2025 from 9:30 AM - 2:00 PM KST
- Room 403, Coex 513, Yeongdong-Daero, Gangnam-gu, Seoul
- Registration: https://m.site.naver.com/1AzcR ð
Japan
- February 20, 2025 from 8:30 AM - 2:00 PM JST
- Fuji Chemical Co., Ltd. 6F Conference Room 2-6-11 Higashitenma, Kita-ku, Osaka 530-0044
- Registration: https://forms.gle/aC7Qm32LHjp5q2ab6
Singapore
- February 24, 2025 from 8:30 AM - 2:00 PM SGT
- Centre of Regulatory Excellence (CoRE) 8 College Road, Singapore 169857
- Registration: https://forms.gle/t52e9QF1Upmmte1A9
Thailand
- February 26, 2025 from 8:30 AM - 2:00 PM ICT
- The Palazzo Bangkok Sorrento Room, 3rd Floor, Grand Palazzo Building
- Registration: https://forms.gle/RN6kDQR3y7PMBfS6A
Virtual Session (Zoom link provided upon registration)
- February 24, 2025
- 12:00pm to 3:30pm (Sydney, Australia Time)
- 9:00am to 12.30pm (Singapore Time)
- Registration: https://forms.gle/XwRZHvcqniF9D5En9